Cargando…
Clinical management and outcomes of primary ovarian leiomyosarcoma – Experience from a sarcoma specialist unit
Ovarian sarcomas account for 1% of all ovarian malignancies and amongst these, primary ovarian leiomyosarcoma is the rarest subtype. Primary ovarian leiomyosarcoma has a very poor prognosis, with less than 20% of patients being alive at 5 years. Only a few cases have been published in the literature...
Autores principales: | Cojocaru, Elena, Palahepitiva Gamage, Githmi, Butler, John, Barton, Desmond P., Thway, Khin, Fisher, Cyril, Messiou, Christina, Miah, Aisha B., Zaidi, Shane, Gennatas, Spyridon, Benson, Charlotte, Huang, Paul, Jones, Robin L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941038/ https://www.ncbi.nlm.nih.gov/pubmed/33732852 http://dx.doi.org/10.1016/j.gore.2021.100737 |
Ejemplares similares
-
Poor treatment outcomes with palliative gemcitabine and docetaxel chemotherapy in advanced and metastatic synovial sarcoma
por: Pender, Alexandra, et al.
Publicado: (2018) -
Clinical Characteristics and efficacy of chemotherapy in sclerosing epithelioid fibrosarcoma
por: Chew, Winston, et al.
Publicado: (2018) -
Pazopanib as first line treatment for solitary fibrous tumours: the Royal Marsden Hospital experience
por: Maruzzo, Marco, et al.
Publicado: (2015) -
Rare Aggressive Behavior of MDM2-Amplified Retroperitoneal Dedifferentiated Liposarcoma, with Brain, Lung and Subcutaneous Metastases
por: Ben Salha, Imen, et al.
Publicado: (2016) -
Histopathological Diagnostic Discrepancies in Soft Tissue Tumours Referred to a Specialist Centre
por: Thway, Khin, et al.
Publicado: (2009)